143 related articles for article (PubMed ID: 24497809)
21. Preoperative characterization of indeterminate large adrenal masses with dual tracer PET-CT using fluorine-18 fluorodeoxyglucose and gallium-68-DOTANOC: initial results.
Naswa N; Sharma P; Soundararajan R; Patnecha M; Lata S; Kumar R; Malhotra A; Bal C
Diagn Interv Radiol; 2013; 19(4):294-8. PubMed ID: 23439252
[TBL] [Abstract][Full Text] [Related]
22. Sporadic Cerebellar Hemangioblastoma With Strong SSTR Expression on 68 Ga-DOTANOC PET/CT.
Dev ID; Rangarajan V; Puranik AD; Agrawal A; Shah S; Sahay A; Purandare NC
Clin Nucl Med; 2023 Jan; 48(1):e28-e30. PubMed ID: 36240749
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of the Added Value of Diffusion-Weighted Imaging to Conventional Magnetic Resonance Imaging in Pancreatic Neuroendocrine Tumors and Comparison With 68Ga-DOTANOC Positron Emission Tomography/Computed Tomography.
Farchione A; Rufini V; Brizi MG; Iacovazzo D; Larghi A; Massara RM; Petrone G; Poscia A; Treglia G; De Marinis L; Giordano A; Rindi G; Bonomo L
Pancreas; 2016 Mar; 45(3):345-54. PubMed ID: 26418904
[TBL] [Abstract][Full Text] [Related]
24. Prospective evaluation of the clinical utility of 18-fluorodeoxyglucose PET CT scanning in patients with von hippel-lindau-associated pancreatic lesions.
Sadowski SM; Weisbrod AB; Ellis R; Patel D; Alimchandani M; Quezado M; Millo C; Venzon DJ; Nilubol N; Linehan WM; Kebebew E
J Am Coll Surg; 2014 May; 218(5):997-1003. PubMed ID: 24661849
[TBL] [Abstract][Full Text] [Related]
25.
Shamim SA; Arora G; Kumar N; Hussain J; Gupta SD; St AR; Shankar K; Goyal A; Khadgawat R; Sagar S; Bal C
Nucl Med Mol Imaging; 2023 Oct; 57(5):235-242. PubMed ID: 37720877
[TBL] [Abstract][Full Text] [Related]
26. von Hippel-Lindau Disease: Review of Genetics and Imaging.
Shanbhogue KP; Hoch M; Fatterpaker G; Chandarana H
Radiol Clin North Am; 2016 May; 54(3):409-22. PubMed ID: 27153780
[TBL] [Abstract][Full Text] [Related]
27. Somatostatin receptor expression on von Hippel-Lindau-associated hemangioblastomas offers novel therapeutic target.
Sizdahkhani S; Feldman MJ; Piazza MG; Ksendzovsky A; Edwards NA; Ray-Chaudhury A; Maric D; Merrill MJ; Pacak K; Zhuang Z; Chittiboina P
Sci Rep; 2017 Jan; 7():40822. PubMed ID: 28094316
[TBL] [Abstract][Full Text] [Related]
28. Endolymphatic Sac Tumor Showing Increased Activity on 68Ga DOTATATE PET/CT.
Papadakis GZ; Millo C; Sadowski SM; Bagci U; Patronas NJ
Clin Nucl Med; 2016 Oct; 41(10):783-4. PubMed ID: 27454593
[TBL] [Abstract][Full Text] [Related]
29. Genotype-phenotype analysis of von Hippel-Lindau syndrome in Korean families: HIF-α binding site missense mutations elevate age-specific risk for CNS hemangioblastoma.
Lee JS; Lee JH; Lee KE; Kim JH; Hong JM; Ra EK; Seo SH; Lee SJ; Kim MJ; Park SS; Seong MW
BMC Med Genet; 2016 Jul; 17(1):48. PubMed ID: 27439424
[TBL] [Abstract][Full Text] [Related]
30. Dual tracer functional imaging of gastroenteropancreatic neuroendocrine tumors using 68Ga-DOTA-NOC PET-CT and 18F-FDG PET-CT: competitive or complimentary?
Naswa N; Sharma P; Gupta SK; Karunanithi S; Reddy RM; Patnecha M; Lata S; Kumar R; Malhotra A; Bal C
Clin Nucl Med; 2014 Jan; 39(1):e27-34. PubMed ID: 24217539
[TBL] [Abstract][Full Text] [Related]
31. De novo VHL germline mutation detected in a patient with mild clinical phenotype of von Hippel-Lindau disease.
Ding X; Zhang C; Frerich JM; Germanwala A; Yang C; Lonser RR; Mao Y; Zhuang Z; Zhang M
J Neurosurg; 2014 Aug; 121(2):384-386. PubMed ID: 24678776
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic values of
Kumar R; Vankadari K; Mittal BR; Bansal D; Trehan A; Sahu JK; Sankhyan N
Eur Radiol; 2021 Jul; 31(7):4587-4594. PubMed ID: 33409780
[TBL] [Abstract][Full Text] [Related]
33. Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET/CT within patients with gastroenteropancreatic neuroendocrine tumors.
Wild D; Bomanji JB; Benkert P; Maecke H; Ell PJ; Reubi JC; Caplin ME
J Nucl Med; 2013 Mar; 54(3):364-72. PubMed ID: 23297077
[TBL] [Abstract][Full Text] [Related]
34. Comparison of ⁶⁸Ga-DOTATATE and ⁶⁸Ga-DOTANOC PET/CT imaging in the same patient group with neuroendocrine tumours.
Kabasakal L; Demirci E; Ocak M; Decristoforo C; Araman A; Ozsoy Y; Uslu I; Kanmaz B
Eur J Nucl Med Mol Imaging; 2012 Aug; 39(8):1271-7. PubMed ID: 22526963
[TBL] [Abstract][Full Text] [Related]
35. The natural history of renal lesions in von Hippel-Lindau disease: a serial CT study in 28 patients.
Choyke PL; Glenn GM; Walther MM; Zbar B; Weiss GH; Alexander RB; Hayes WS; Long JP; Thakore KN; Linehan WM
AJR Am J Roentgenol; 1992 Dec; 159(6):1229-34. PubMed ID: 1442389
[TBL] [Abstract][Full Text] [Related]
36. Utility of Gallium-68 DOTANOC PET/CT in the localization of Tumour-induced osteomalacia.
Bhavani N; Reena Asirvatham A; Kallur K; Menon AS; Pavithran PV; Nair V; Vasukutty JR; Menon U; Kumar H
Clin Endocrinol (Oxf); 2016 Jan; 84(1):134-40. PubMed ID: 25996566
[TBL] [Abstract][Full Text] [Related]
37. The impact of molecular genetic analysis of the VHL gene in patients with haemangioblastomas of the central nervous system.
Gläsker S; Bender BU; Apel TW; Natt E; van Velthoven V; Scheremet R; Zentner J; Neumann HP
J Neurol Neurosurg Psychiatry; 1999 Dec; 67(6):758-62. PubMed ID: 10567493
[TBL] [Abstract][Full Text] [Related]
38. Isolated cardiac metastasis in a patient with neuroendocrine carcinoma of pancreas discovered on ⁶⁸Ga-DOTANOC PET/CT.
Khangembam BC; Naswa N; Sharma P; Bal C; Malhotra A; Kumar R
J Nucl Cardiol; 2012 Oct; 19(5):1078-9. PubMed ID: 22538764
[TBL] [Abstract][Full Text] [Related]
39. Hemangioblastomas of the central nervous system. A 10-year study with special reference to von Hippel-Lindau syndrome.
Neumann HP; Eggert HR; Weigel K; Friedburg H; Wiestler OD; Schollmeyer P
J Neurosurg; 1989 Jan; 70(1):24-30. PubMed ID: 2909683
[TBL] [Abstract][Full Text] [Related]
40. [Integrated diagnosis of kidney involvement in Hippel-Lindau syndrome].
Bonatti G; Ortore P; Riegler P; Koenigsrainer A; Neumann H
Radiol Med; 1990 Dec; 80(6):938-41. PubMed ID: 2281182
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]